[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 162, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL", "age": 59, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 3332915, "exercisedValue": 0, "unexercisedValue": 3757481}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 56, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2936973, "exercisedValue": 0, "unexercisedValue": 520353}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 706970, "exercisedValue": 0, "unexercisedValue": 4750777}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 58, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lynda  Harris", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 35, "title": "Chief Business Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 73, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.09, "open": 11.15, "dayLow": 10.6, "dayHigh": 11.15, "regularMarketPreviousClose": 11.09, "regularMarketOpen": 11.15, "regularMarketDayLow": 10.6, "regularMarketDayHigh": 11.15, "payoutRatio": 0.0, "beta": 0.739, "forwardPE": -7.874074, "volume": 1032824, "regularMarketVolume": 1032824, "averageVolume": 1971090, "averageVolume10days": 2151310, "averageDailyVolume10Day": 2151310, "bid": 8.03, "ask": 13.61, "bidSize": 2, "askSize": 2, "marketCap": 1050760704, "fiftyTwoWeekLow": 6.66, "fiftyTwoWeekHigh": 18.9, "allTimeHigh": 63.41, "allTimeLow": 2.55, "priceToSalesTrailing12Months": 7.359711, "fiftyDayAverage": 9.9615, "twoHundredDayAverage": 12.7395, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1983117440, "profitMargins": -0.56061, "floatShares": 105406228, "sharesOutstanding": 98848611, "sharesShort": 20509054, "sharesShortPriorMonth": 20664949, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.2075, "heldPercentInsiders": 0.16826001, "heldPercentInstitutions": 0.8711, "shortRatio": 12.95, "shortPercentOfFloat": 0.338, "impliedSharesOutstanding": 98848611, "bookValue": 1.494, "priceToBook": 7.1151276, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -80040000, "trailingEps": -0.81, "forwardEps": -1.35, "enterpriseToRevenue": 13.89, "enterpriseToEbitda": -22.082, "52WeekChange": -0.21142435, "SandP52WeekChange": 0.14725316, "quoteType": "EQUITY", "currentPrice": 10.63, "targetHighPrice": 39.0, "targetLowPrice": 12.0, "targetMeanPrice": 28.83333, "targetMedianPrice": 31.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 288208992, "totalCashPerShare": 1.458, "ebitda": -89807000, "totalDebt": 169804992, "quickRatio": 6.406, "currentRatio": 6.66, "totalRevenue": 142772000, "debtToEquity": 115.001, "revenuePerShare": 1.454, "returnOnAssets": -0.19221, "returnOnEquity": -0.45916, "grossProfits": 114873000, "freeCashflow": -56190248, "operatingCashflow": -85377000, "revenueGrowth": 14.716, "grossMargins": 0.80459, "ebitdaMargins": -0.62902, "operatingMargins": -1.6366299, "financialCurrency": "USD", "symbol": "SPRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "earningsTimestampEnd": 1762781400, "earningsCallTimestampStart": 1762781400, "earningsCallTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.81, "epsForward": -1.35, "epsCurrentYear": -1.7875, "priceEpsCurrentYear": -5.946853, "fiftyDayAverageChange": 0.66849995, "fiftyDayAverageChangePercent": 0.06710836, "twoHundredDayAverageChange": -2.1095, "twoHundredDayAverageChangePercent": -0.16558734, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Silverback Therapeutics, Inc.", "nameChangeDate": "2026-01-16", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607092200000, "postMarketChangePercent": 1.1288794, "postMarketPrice": 10.75, "postMarketChange": 0.119999886, "regularMarketChange": -0.46, "regularMarketDayRange": "10.6 - 11.15", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1971090, "fiftyTwoWeekLowChange": 3.9700003, "fiftyTwoWeekLowChangePercent": 0.59609616, "fiftyTwoWeekRange": "6.66 - 18.9", "fiftyTwoWeekHighChange": -8.2699995, "fiftyTwoWeekHighChangePercent": -0.43756613, "fiftyTwoWeekChangePercent": -21.142435, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "gmtOffSetMilliseconds": -18000000, "esgPopulated": false, "regularMarketChangePercent": -4.14788, "regularMarketPrice": 10.63, "corporateActions": [], "postMarketTime": 1768609171, "regularMarketTime": 1768597201, "exchange": "NGM", "messageBoardId": "finmb_585213447", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "market": "us_market", "displayName": "ARS Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]